Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 19, 2018

SELL
$166.05 - $186.51 $95.3 Million - $107 Million
-573,942 Closed
0 $0
Q1 2018

Apr 13, 2018

BUY
$169.43 - $198.0 $40.1 Million - $46.9 Million
236,730 Added 70.2%
573,942 $97.8 Million
Q4 2017

Feb 22, 2018

BUY
$168.79 - $188.59 $56.9 Million - $63.6 Million
337,212
337,212 $58.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Adamcapital Gestao De Recursos Ltda. Portfolio

Follow Adamcapital Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adamcapital Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Adamcapital Gestao De Recursos Ltda. with notifications on news.